The pharmaceutical industry and access and benefit-sharing

Kern, Florian (2007) The pharmaceutical industry and access and benefit-sharing. In: European Regional Meeting on an Internationally Recognized Certificate of Origin / Source / Legal Provenance, 24 - 29 October 2006., Isle of Vilm, Germany..

Full text not available from this repository.

Abstract

My contribution is based on an analysis of the voluntary realisation of the Access and Benfit-Sharing (ABS) stipulations of the UN Convention on Biological Diversity (CBD) by the pharmaceutical industry. Our research shows that on a voluntary basis the pharmaceutical industry realises ABS provisions of the CBD only to a very limited extent. We thus argue for the necessity of an legally binding ABS protocol on the basis of the Bonn guidelines.

Item Type: Conference or Workshop Item (Paper)
Schools and Departments: School of Business, Management and Economics > SPRU - Science Policy Research Unit
Depositing User: Florian Kern
Date Deposited: 06 Feb 2012 20:34
Last Modified: 08 Oct 2012 10:59
URI: http://sro.sussex.ac.uk/id/eprint/26674
📧 Request an update